in 2020 identified that the 3′-UTR shortening of fibronectin type III domain containing 3B (FNDC3B) mRNA mediated its overexpression in Nasopharyngeal carcinoma(NPC)and promoted NPC progression by targeting myosin heavy chain 9 (MYH9) (62). This evidence concerns the gene MYH9 and nasopharyngeal carcinoma.